Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Classificação em ações #26682
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Preço da ação
$3.49
Última sincronização: 2023-12-19
Valor de mercado
$38.68M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Neoleukin Therapeutics, Inc. (NLTX)

Categoria

Histórico de preços das ações de Neoleukin Therapeutics, Inc. (NLTX)
Preço de fecho mais alto: $3.45 em 2023-12-01

Preço de fecho mais baixo: $64.26 em 2014-03-01
Histórico de preços das ações da Neoleukin Therapeutics, Inc. de 2014 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 54.08%
2022 -91.29%
2021 -59.35%
2020 43.82%
2019 289.17%
2018 -79.56%
2017 -28.51%
2016 28.68%
2015 63.39%
2014 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$171.67 -
DE
$163.33 25.54%
DE
$38.00 22.72%
JP
$220.12 32.96%
CH
$21.01 11.96%
IN